Oncodesign Services will be in Boston from 11th to 15th October 2023
We are proud to be part of this new edition of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, which will take place in Boston (US) from 11 to 15 october 2023!
Exchange with our team
 |
 |
|
Sylvie Maubant, PhD Head of study & Research Unit |
Carol Gebert, PhD Business Development Manager |
A multi-disciplinary capabilities in oncology
- Medicinal Chemistry capabilities : Oncodesign Services offers hit finding, hit-to-lead, lead optimization and preclinical development for your research programs.
- Advanced imaging platform : Oncodesign Services offers advanced imaging technologies to visualize in real time tumor growth, treatment response and drug distribution
- In vitro screening: Oncodesign Services offers both off-the-shell assays using commercial kits and in-house developed assays with customized reagent panels.
- In vivo modelling: In vivo pharmacology is one of Oncodesign Services’ core strengths. We offer preclinical pharmacology services from all three of our locations.
- PK/PD studies : Oncodesign Services is ability to conduct detailed pharmacokinetic and pharmacodynamic studies that provide critical insights into drug interaction with tumor and body.
More about the congress
Hosted by the American Association for Cancer Research, the National Cancer Institute, and the European Organisation for Research and Treatment of Cancer, the 2023 Molecular Targets and Cancer Therapeutics conference will return to the Hynes Convention Center in Boston.
This program attracts 1,200-1,500 academics, scientists, and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection, the impact of new discoveries in cellular and molecular biology, and early clinical trials.